Annual short term debt:
$6.95B-$3.40B(-32.86%)Summary
- As of today (June 22, 2025), PFE annual short term debt is $6.95 billion, with the most recent change of -$3.40 billion (-32.86%) on December 31, 2024.
- During the last 3 years, PFE annual short term debt has risen by +$4.71 billion (+209.95%).
- PFE annual short term debt is now -57.10% below its all-time high of $16.19 billion, reached on December 31, 2019.
Performance
PFE Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$4.47B-$2.48B(-35.63%)Summary
- As of today (June 22, 2025), PFE quarterly short term debt is $4.47 billion, with the most recent change of -$2.48 billion (-35.63%) on March 29, 2025.
- Over the past year, PFE quarterly short term debt has dropped by -$3.76 billion (-45.68%).
- PFE quarterly short term debt is now -73.08% below its all-time high of $16.61 billion, reached on September 29, 2019.
Performance
PFE quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PFE Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.9% | -45.7% |
| 3 y3 years | +209.9% | +603.0% |
| 5 y5 years | -57.1% | -72.1% |
PFE Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | +209.9% | -62.6% | +75.5% |
| 5 y | 5-year | -57.1% | +209.9% | -72.1% | +603.0% |
| alltime | all time | -57.1% | +3636.4% | -73.1% | +2305.1% |
PFE Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $4.47B(-35.6%) |
| Dec 2024 | $6.95B(-32.9%) | $6.95B(-28.4%) |
| Sep 2024 | - | $9.70B(-18.8%) |
| Jun 2024 | - | $11.94B(+45.1%) |
| Mar 2024 | - | $8.23B(-20.4%) |
| Dec 2023 | $10.35B(+252.6%) | $10.35B(+306.0%) |
| Sep 2023 | - | $2.55B(-36.1%) |
| Jun 2023 | - | $3.98B(-4.9%) |
| Mar 2023 | - | $4.19B(+42.8%) |
| Dec 2022 | $2.93B(+30.9%) | $2.93B(-27.1%) |
| Sep 2022 | - | $4.02B(-32.5%) |
| Jun 2022 | - | $5.96B(+837.9%) |
| Mar 2022 | - | $636.00M(-71.6%) |
| Dec 2021 | $2.24B(-17.1%) | $2.24B(-38.2%) |
| Sep 2021 | - | $3.63B(-6.7%) |
| Jun 2021 | - | $3.89B(-10.7%) |
| Mar 2021 | - | $4.35B(+61.0%) |
| Dec 2020 | $2.70B(-83.3%) | $2.70B(-79.8%) |
| Sep 2020 | - | $13.36B(+2.1%) |
| Jun 2020 | - | $13.08B(-18.3%) |
| Mar 2020 | - | $16.00B(-1.1%) |
| Dec 2019 | $16.19B(+83.2%) | $16.19B(-2.5%) |
| Sep 2019 | - | $16.61B(+58.1%) |
| Jun 2019 | - | $10.51B(+11.6%) |
| Mar 2019 | - | $9.41B(+6.5%) |
| Dec 2018 | $8.84B(-11.1%) | $8.84B(-40.2%) |
| Sep 2018 | - | $14.78B(+27.6%) |
| Jun 2018 | - | $11.59B(+28.7%) |
| Mar 2018 | - | $9.00B(-9.4%) |
| Dec 2017 | $9.94B(-6.8%) | $9.94B(+5.2%) |
| Sep 2017 | - | $9.45B(-0.7%) |
| Jun 2017 | - | $9.51B(+23.9%) |
| Mar 2017 | - | $7.68B(-28.0%) |
| Dec 2016 | $10.66B(+5.0%) | $10.66B(-21.8%) |
| Sep 2016 | - | $13.63B(-0.7%) |
| Jun 2016 | - | $13.72B(+18.9%) |
| Mar 2016 | - | $11.55B(+13.7%) |
| Dec 2015 | $10.16B(+97.6%) | $10.16B(+3.5%) |
| Sep 2015 | - | $9.82B(+17.0%) |
| Jun 2015 | - | $8.39B(+28.1%) |
| Mar 2015 | - | $6.55B(+27.5%) |
| Dec 2014 | $5.14B(-14.7%) | $5.14B(-4.6%) |
| Sep 2014 | - | $5.39B(-3.1%) |
| Jun 2014 | - | $5.56B(-40.3%) |
| Mar 2014 | - | $9.32B(+54.6%) |
| Dec 2013 | $6.03B(-6.2%) | $6.03B(+27.2%) |
| Sep 2013 | - | $4.74B(-9.1%) |
| Jun 2013 | - | $5.21B(-41.4%) |
| Mar 2013 | - | $8.90B(+38.5%) |
| Dec 2012 | $6.42B(+60.0%) | $6.42B(-17.4%) |
| Sep 2012 | - | $7.77B(+0.9%) |
| Jun 2012 | - | $7.70B(+39.4%) |
| Mar 2012 | - | $5.53B(+37.6%) |
| Dec 2011 | $4.02B(-28.6%) | $4.02B(-28.8%) |
| Sep 2011 | - | $5.64B(-5.9%) |
| Jun 2011 | - | $5.99B(-1.7%) |
| Mar 2011 | - | $6.09B(+8.4%) |
| Dec 2010 | $5.62B(+2.8%) | $5.62B(+9.0%) |
| Sep 2010 | - | $5.16B(-6.4%) |
| Jun 2010 | - | $5.51B(-29.1%) |
| Mar 2010 | - | $7.77B(+42.1%) |
| Dec 2009 | $5.47B(-41.3%) | $5.47B(-21.4%) |
| Sep 2009 | - | $6.95B(-9.0%) |
| Jun 2009 | - | $7.64B(+0.4%) |
| Mar 2009 | - | $7.61B(-18.3%) |
| Dec 2008 | $9.32B(+60.0%) | $9.32B(+1.4%) |
| Sep 2008 | - | $9.19B(-2.7%) |
| Jun 2008 | - | $9.45B(+6.1%) |
| Mar 2008 | - | $8.91B(+52.9%) |
| Dec 2007 | $5.83B(+139.3%) | $5.83B(+120.2%) |
| Sep 2007 | - | $2.65B(+8.8%) |
| Jun 2007 | - | $2.43B(-7.8%) |
| Mar 2007 | - | $2.64B(+8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $2.43B(-79.0%) | $2.43B(-3.0%) |
| Sep 2006 | - | $2.51B(-33.6%) |
| Jun 2006 | - | $3.78B(-25.3%) |
| Mar 2006 | - | $5.06B(-56.3%) |
| Dec 2005 | $11.59B(+2.9%) | $11.59B(+72.2%) |
| Sep 2005 | - | $6.73B(-7.3%) |
| Jun 2005 | - | $7.26B(-45.8%) |
| Mar 2005 | - | $13.40B(+18.9%) |
| Dec 2004 | $11.27B(+27.8%) | $11.27B(+3.8%) |
| Sep 2004 | - | $10.86B(-11.0%) |
| Jun 2004 | - | $12.20B(+14.1%) |
| Mar 2004 | - | $10.69B(+21.3%) |
| Dec 2003 | $8.82B(+1.7%) | $8.82B(-6.2%) |
| Sep 2003 | - | $9.40B(+14.4%) |
| Jun 2003 | - | $8.21B(-11.3%) |
| Mar 2003 | - | $9.27B(+6.9%) |
| Dec 2002 | $8.67B(+38.4%) | $8.67B(-18.9%) |
| Sep 2002 | - | $10.69B(+27.8%) |
| Jun 2002 | - | $8.37B(+8.0%) |
| Mar 2002 | - | $7.75B(+23.7%) |
| Dec 2001 | $6.26B(+46.0%) | $6.26B(-1.6%) |
| Sep 2001 | - | $6.36B(+37.2%) |
| Jun 2001 | - | $4.64B(+17.0%) |
| Mar 2001 | - | $3.96B(-7.6%) |
| Dec 2000 | $4.29B(-19.1%) | $4.29B(-27.7%) |
| Sep 2000 | - | $5.93B(+7.0%) |
| Jun 2000 | - | $5.54B(+49.2%) |
| Mar 2000 | - | $3.72B(-29.9%) |
| Dec 1999 | $5.30B(+94.2%) | $5.30B(-3.4%) |
| Sep 1999 | - | $5.49B(+11.1%) |
| Jun 1999 | - | $4.94B(+14.9%) |
| Mar 1999 | - | $4.30B(+57.4%) |
| Dec 1998 | $2.73B(+21.2%) | $2.73B(-18.5%) |
| Sep 1998 | - | $3.35B(+29.7%) |
| Jun 1998 | - | $2.58B(+2.7%) |
| Mar 1998 | - | $2.52B(+11.7%) |
| Dec 1997 | $2.25B(+0.7%) | $2.25B(-21.0%) |
| Sep 1997 | - | $2.85B(-4.3%) |
| Jun 1997 | - | $2.98B(+15.3%) |
| Mar 1997 | - | $2.58B(+15.5%) |
| Dec 1996 | $2.23B(+9.8%) | $2.23B(-29.2%) |
| Sep 1996 | - | $3.16B(+24.0%) |
| Jun 1996 | - | $2.54B(+8.8%) |
| Mar 1996 | - | $2.34B(+14.9%) |
| Dec 1995 | $2.04B(-8.3%) | $2.04B(-33.2%) |
| Sep 1995 | - | $3.05B(-0.4%) |
| Jun 1995 | - | $3.06B(-1.8%) |
| Mar 1995 | - | $3.12B(+40.3%) |
| Dec 1994 | $2.22B(+88.3%) | $2.22B(+23.6%) |
| Sep 1994 | - | $1.80B(-2.1%) |
| Jun 1994 | - | $1.84B(+21.0%) |
| Mar 1994 | - | $1.52B(+28.8%) |
| Dec 1993 | $1.18B(-5.9%) | $1.18B(-46.9%) |
| Sep 1993 | - | $2.22B(+2.8%) |
| Jun 1993 | - | $2.16B(+17.4%) |
| Mar 1993 | - | $1.84B(+46.9%) |
| Dec 1992 | $1.25B(-25.9%) | $1.25B(-1.6%) |
| Sep 1992 | - | $1.27B(+20.5%) |
| Jun 1992 | - | $1.06B(-18.3%) |
| Mar 1992 | - | $1.29B(-23.6%) |
| Dec 1991 | $1.69B(+12.8%) | $1.69B(+1.4%) |
| Sep 1991 | - | $1.67B(+7.0%) |
| Jun 1991 | - | $1.56B(+23.5%) |
| Mar 1991 | - | $1.26B(-15.9%) |
| Dec 1990 | $1.50B(-1.8%) | $1.50B(+19.2%) |
| Sep 1990 | - | $1.26B(+15.5%) |
| Jun 1990 | - | $1.09B(+10.0%) |
| Mar 1990 | - | $990.20M(-35.1%) |
| Dec 1989 | $1.53B(+57.7%) | $1.53B(+57.7%) |
| Dec 1988 | $967.70M(+35.4%) | $967.70M(+35.4%) |
| Dec 1987 | $714.90M(+163.5%) | $714.90M(+163.5%) |
| Dec 1986 | $271.30M(+45.9%) | $271.30M(+45.9%) |
| Dec 1985 | $185.90M(-37.8%) | $185.90M(-37.8%) |
| Dec 1984 | $298.90M | $298.90M |
FAQ
- What is Pfizer annual short term debt?
- What is the all time high annual short term debt for Pfizer?
- What is Pfizer annual short term debt year-on-year change?
- What is Pfizer quarterly short term debt?
- What is the all time high quarterly short term debt for Pfizer?
- What is Pfizer quarterly short term debt year-on-year change?
What is Pfizer annual short term debt?
The current annual short term debt of PFE is $6.95B
What is the all time high annual short term debt for Pfizer?
Pfizer all-time high annual short term debt is $16.19B
What is Pfizer annual short term debt year-on-year change?
Over the past year, PFE annual short term debt has changed by -$3.40B (-32.86%)
What is Pfizer quarterly short term debt?
The current quarterly short term debt of PFE is $4.47B
What is the all time high quarterly short term debt for Pfizer?
Pfizer all-time high quarterly short term debt is $16.61B
What is Pfizer quarterly short term debt year-on-year change?
Over the past year, PFE quarterly short term debt has changed by -$3.76B (-45.68%)